The GMO Growth Story Is Not Over Yet
The GMO growth story has stalled, but it is far from over. Following the introduction of GMOs in 1996, GMO sales grew at a 35% average annual pace to 2013. Over the past few years, growth has ground to a halt, with major markets in North and South America reaching saturation and crop prices sinking from elevated levels. Reputational challenges haven't helped. More food companies are proudly labeling their products "GMO-free," more than half of EU members ban GMO planting, and some research casts...
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.